We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Rapid Diagnostic Test Evaluated for Gram-Positive Bloodstream Infections

By LabMedica International staff writers
Posted on 13 Jan 2015
A microarray-based rapid diagnostic test, which includes targets for 12 bacterial species and three resistance determinants, has been compared to routine microbiologic methods for diagnostic accuracy. More...


Overall mortality in patients with Gram-positive bacteremia ranges from 10% to 40%, with delays in effective antimicrobial therapy leading to a dramatic increase in mortality and patients with Gram-positive bacteremia also often suffer from substantial long-term morbidity as a result of prolonged hospitalization and generalized deconditioning.

Scientists at the University of Houston (TX, USA) and their colleagues examined blood cultures submitted as part of routine clinical care to a 650-bed tertiary care hospital. All blood cultures with Gram stain identification of Gram-positive cocci between October and December 2013 were prospectively screened for eligibility. Blood cultures were obtained using BacT/ALERT (bioMérieux; Durham, NC, USA) aerobic (FA) and anaerobic (SN) blood culture bottles and incubated in the bioMérieux BacT/ALERT 3D automatic monitoring system.

The Verigene Gram-positive blood culture assay (BC-GP, Nanosphere, Inc.; Northbrook, IL, USA) is a microarray-based rapid diagnostic test that identifies molecular target through DNA extraction and subsequent hybridization to complementary oligonucleotides present on the microarray grid. A secondary oligonucleotide affixed to a gold nanoparticle is then hybridized to captured bacterial DNA, and the target is identified through analysis of the relative optical density of the probes on the panel. Total hands-on time was approximately 10 minutes with a 2.5-hour test run time.

A total of 143 consecutive patients with Gram-positive bacteremia were included in the analysis. BC-GP correctly identified 127/128 (99.2%) of organisms from monomicrobial blood cultures and 9/14 (64.3%) from polymicrobial, including all methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Stewardship interventions were possible in 51.0% of patients, most commonly stopping or preventing unnecessary vancomycin or starting a targeted therapy.

The authors concluded that the BC-GP is a potentially useful tool for antimicrobial stewardship programs to improve the care of patients with Gram-positive bacteremia. In Monte Carlo simulations, unnecessary antibiotics could be stopped at least 24 hours earlier in 65.6% of cases, and targeted therapy could be started at least 24 hours earlier for 81.2% of the patients. The study was published in the January 2015 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of Houston
bioMérieux 
Nanosphere, Inc. 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.